Section 22-B3920. INTRAVENOUS THERAPY SERVICES

 

3920.1If intravenous therapy services are provided, they shall be provided in accordance with the patient's plan of care and administered by a registered nurse or licensed practical nurse who shall have training or experience in intravenous therapy.

 

3920.2The intravenous therapy service plan shall include, at a minimum, the following:

 

(a)Type, amount, flow rate, duration, and mode of administration of nutritional formula or intravenous solution;

 

(b)Type, dosage, frequency, duration, and mode of administration of medication;

 

(c)Type and frequency of laboratory tests to be monitored;

 

(d)Information on use of an anticoagulant in connection with intermittent intravenous therapy; and

 

(e)Specific laboratory test limits.

 

3920.3Each clinical record shall include, at a minimum, the following information related to intravenous therapy:

 

(a)The intravenous therapy service plan, as ordered by the patient's physician;

 

(b)A copy of the consent form for intravenous therapy executed by the provider of the intravenous therapy product, or a copy of the consent form for intravenous therapy executed by the home care agency, including risks, benefits and alternatives;

 

(c)Documentation of training provided to the patient, patient's caregiver, or other responsible person in intravenous therapy;

 

(d)Information on composition, amount, rate, mode, duration, date, and time of administration of nutrition, medication, and intravenous solution;

 

(e)History of drug allergies and adverse reaction to medication therapy;

 

(f)Date and time of venous access insertion, and type and gauge of needle or catheter used;

 

(g)Information on change of solution, intravenous fluid administration, filter, tubing, and dressings;

 

(h)Observation of the patient and the access site;

 

(i)Laboratory monitoring;

 

(j)Information on all medication administered, including type, dosage, frequency, duration, route of administration, and toxic or side effects;

 

(k)Progress notes at least every thirty (30) calendar days; and

 

(l)A summary report at least every sixty-two (62) calendar days.

 

3920.4The first dosage of an antibiotic or chemotherapy shall not be administered by a home care agency, unless an anaphylactic kit is immediately available for administration.

 

3920.5The home care agency shall have written policies and procedures concerning intravenous therapy that address the following:

 

(a)Patient selection criteria;

 

(b)Monitoring of patients and emergency care;

 

(c)Availability of care twenty-four (24) hours a day and continuity of care;

 

(d)Preparation and storage of intravenous solutions, special nutrition formulas, and medications;

 

(e)Infection control;

 

(f)Disposal of sharps, catheters, tubing and dressings;

 

(g)Equipment care and maintenance;

 

(h)Administration guidelines, including adverse reaction protocol;

 

(i)Obtaining medical supplies;

 

(j)Blood transfusions; and

 

(k)Adverse reactions.

 

source

Final Rulemaking published at 51 DCR 2876 (March 19, 2004).